BRIEF-Agile Therapeutics Reports Q4 Loss Per Share $0.18

* Q4 LOSS PER SHARE $0.18

* Q4 EARNINGS PER SHARE VIEW $-0.24 — THOMSON REUTERS I/B/E/S

* AGILE THERAPEUTICS - BELIEVES CASH AND CASH EQUIVALENTS AS OF DEC 31, 2017, TO BE SUFFICIENT TO MEET ITS OPERATING REQUIREMENTS THROUGH END OF 2018 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)